New Trends in Dual 5-LOX / COX Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|9|941-962

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.9, 2002-05, pp. : 941-962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

By Charlier C.   Michaux C.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 645-659

Elsevier

Access to resources Recommend Favorite

Recent Development in the Field of Dual COX / 5-LOX Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 633-638

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2/5-LOX Dual Acting Anti-Inflammatory Drugs in Cancer Chemotherapy

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 283-296

Bentham Science Publishers

Access to resources Recommend Favorite

Dual COX Inhibition and Upper Gastrointestinal Damage

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2191-2195

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

By de Gaetano G.   Donati M.B.   Cerletti C.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite